Recently it has been reported that AR injections improved the levels of T lymphocyte subsets CD3+, CD4+ and CD4+/CD8+, and reduced symptoms in children with lupus nephritis [159], as well as the incidence of nausea and vomiting, hyperhidrosis, hemorrhage, and infections in leukemia patients following chemotherapy [160]. The gene discussed is CD4; the disease is lupus nephritis.